U.S. Physical Therapy Inc. Appoints Myra Davis to Board

What Happened
U.S. Physical Therapy Inc. (USPH) filed an 8-K on September 21, 2026 (Item 5.02) reporting that its Board approved the appointment of Myra Davis as a director, effective October 1, 2026. The Board approved the appointment on September 15, 2026. Ms. Davis, age 61, is Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and has held senior IT and innovation roles there since 2003.

Key Details

• Appointment effective date: October 1, 2026; Board approval date: September 15, 2026.
• Current role: Executive Vice President & Chief Information Innovation Officer, Texas Children’s Hospital (since 2023); prior roles include Senior VP & Chief Information and Innovation Officer (2019–2023) and CIO (2009–2019).
• Board/external roles: Director of Werfen (medical diagnostics) and member of the Healthcare Information Management Systems Society advisory board.
• Compensation: Upon joining, Ms. Davis will receive the standard annual cash retainer and annual equity grant in amounts determined per the Company’s director compensation policy disclosed in the April 16, 2026 proxy.
• Governance notes: As of the 8‑K filing, she has not been assigned to any Board committee; no related‑party transactions were reported.

Why It Matters
The company added a director with extensive CIO‑level healthcare IT and digital transformation experience, which could strengthen the Board’s expertise in technology, innovation, and healthcare operations oversight. The filing is a routine governance disclosure; investors should note the effective date (Oct 1, 2026), compensation will follow existing director pay practices, and no committee assignment or reportable related‑party transactions were disclosed.